|
|||||
|
|
European guidelines for workplace drug testing in oral fluid |
|
| Authors: | Michaela Brcak Olof Beck Tessa Bosch Duncan Carmichael Nadia Fucci Claire George Mark Piper Alberto Salomone Wim Schielen Stefan Steinmeyer Sanna Taskinen Wolfgang Weinmann |
| Affiliation: | 1. Greiner Bio‐One GmbH, Kremsmünster, Austria;2. Karolinska Institutet, Department of Laboratory Medicine, Stockholm, Sweden;3. Department Clinical Pharmacology & Toxicology, Hospital Pharmacy, MaastadLab, Rotterdam, Netherlands;4. AgriYork 400 Limited, York, United Kingdom;5. Institute of Public Health – Section of Legal Medicine, Catholic University, Rome, Italy;6. Alere Toxicology Plc, Oxfordshire, United Kingdom;7. Randox Testing Services, United Kingdom;8. Centro Regionale Antidoping e di Tossicologia ‘A. Bertinaria’, Torino, Italy;9. ELDC BV / BeterVee BV, Kerkrade, Netherlands;10. Dr?ger Safety AG & Co. KGaA, Lübeck, Germany;11. VITA Laboratory, VITA Healthcare Services Ltd, Helsinki Finland;12. Institute of Forensic Medicine, University of Bern, Switzerland |
| Abstract: | These guidelines for Legally Defensible Workplace Drug Testing have been prepared and updated by the European Workplace Drug Testing Society (EWDTS). The European Guidelines are designed to establish best practice procedures whilst allowing individual countries to operate within the requirements of national customs and legislation. The EWDTS recommends that all European laboratories that undertake legally defensible workplace drug testing should use these guidelines as a template for accreditation. These guidelines are relevant to laboratory‐based testing only. These guidelines follow current best practices and are constantly under review. |
| Keywords: | EWDTS guidelines oral fluid workplace drug testing |